Увійти

Готові списки джерел за темами / Genetically engineered drugs

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій

Добірка наукової літератури з теми "Genetically engineered drugs"

Автор: Grafiati

Опубліковано: 27 травня 2023

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Genetically engineered drugs".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Genetically engineered drugs"

1

Jones-Grizzle, Amy J., and J. Lyle Bootman. "Pharmacoeconomics of Genetically Engineered Drugs." PharmacoEconomics 1, no. 1 (1992): 45–53. http://dx.doi.org/10.2165/00019053-199201010-00009.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Kishore, Kamal, and Pawan Krishan. "Pharmacology of recombinant or genetically engineered drugs." Journal of Young Pharmacists 1, no. 2 (2009): 141. http://dx.doi.org/10.4103/0975-1483.55747.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Khobeysh, M. M., and E. V. Sokolovskiy. "Genetically engineered biologics to treat psoriasis. Experience with ustekinumab in an adolescent with severe psoriasis." Meditsinskiy sovet = Medical Council, no. 1 (March 12, 2023): 123–29. http://dx.doi.org/10.21518/ms2023-003.

Повний текст джерела

Анотація:

Modern pathogenetic therapy of psoriasis is the use of suppressive methods aimed to suppress immune reactions in the dermis, synovia, enthesis and eliminate the imbalance between anti-inflammatory and pro-inflammatory cytokines, chemokines. Today, genetically engineered biological drugs are one of the most promising pharmacotherapy achievements for the management of psoriasis, psoriatic arthritis in the group of immunosuppressive agents. Knowing the pathogenetic mechanisms that underlie the development of these diseases allows us today to highly selectively target the top key links of the immu

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Матюнова, Алла, Alla Matyunova, Людмила Брегель, and Lyudmila Bregel. "MODERN JUVENILE IDIOPATHIC ARTHRITIS THERAPY OF WITH THE USE OF BIOLOGICAL MEDICATIONS IN A REGIONAL CHILDREN”S 3 LEVEL HOSPITAL - RESULTS AND PROBLEMS." Acta biomedica scientifica 2, no. 5 (2018): 102–6. http://dx.doi.org/10.12737/article_5a3a0e4744a0a8.88140750.

Повний текст джерела

Анотація:

Background. Juvenile idiopathic arthritis is accompanied by severe functional disabilities refractory to standard treat- ment with methotrexate. Recently introduced genetic engineering has significantly improved the functional state of the patients with persistent disease and stopped the progressive destruction of joints. However, the risk of adverse reactions against the background of this type of therapy requires further study. Aims: to analyze the efficiency of the genetically engineered drugs applied at juvenile arthritis and undesirable effects of this treatm

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Huang, Ya Qiong, Kenneth L. White, De Shun Shi, et al. "Development and Prospect of Genetically Engineered Pharmaceutics." Advanced Materials Research 746 (August 2013): 588–92. http://dx.doi.org/10.4028/www.scientific.net/amr.746.588.

Повний текст джерела

Анотація:

With the rapid development of modern biology and technology, Genetically Engineered Pharmaceutics has become the most important field in modern medicinal industry. Currently, we have taken concern that the Genetically Engineered Pharmaceutics has been a subject of research. As advanced genetically engineered technology, genetic therapy, the point mutation techniques, DNA shuffling, RNA interference (RNAi) technology, the bioinformatics for genome and proteome analyses, the high throughput screening technology, etc. can be applied in the treatment of cancer, and other targeted therapies. A grea

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Zyryanov, S. K., and O. I. Butranova. "Genetically engineered drugs for treatment of bronchial asthma: recent achievements." Russian Pulmonology 28, no. 5 (2018): 584–601. http://dx.doi.org/10.18093/0869-0189-2018-28-5-584-601.

Повний текст джерела

Анотація:

Current population of patients with asthma is characterized by increasing resistance to standard pharmacotherapeutic agents such as inhaled corticosteroids, antileukotriene agents and anti-IgE antibodies. These findings were confirmed by international statistic data and indicate insufficient efficacy of the treatment. Asthma phenotyping encompassing a role of certain biomarkers for bronchial inflammation could contribute to achieving better response to treatment. Genetically engineered drugs could directly impact on mediators and modulators involved in the inflammation and bronchoconstriction.

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Leonova, K. "Selected problems in the use of genetic engineering biological therapy in patients with rheumatoid arthritis." Clinical Medicine and Pharmacology 6, no. 4 (2021): 36–39. http://dx.doi.org/10.12737/2409-3750-2021-6-4-36-39.

Повний текст джерела

Анотація:

Rheumatoid arthritis, like any chronic non-infectious disease, requires constant pharmacological therapy and monitoring of treatment. To relieve exacerbation, maintain long-term remission and improve the quality of life of patients, basic anti-inflammatory drugs are used, which have passed many years of testing for efficacy and safety and are available for patients. But there is a group of drugs that have appeared relatively recently - genetically engineered biological drugs. At the moment, their use is somewhat limited due to the presence of a number of problems. With the accumulation of data

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Avdeev, Sergey N., Alexandr V. Emelyanov, Oksana M. Kurbacheva, et al. "A new delivery device for benralizumab (autoinjector, pen-injector device) in the clinical practice of treating severe eosinophilic asthma: Conclusion of the Expert Council." PULMONOLOGIYA 31, no. 6 (2021): 776–81. http://dx.doi.org/10.18093/0869-0189-2021-31-6-776-781.

Повний текст джерела

Анотація:

The emergence of new means of administering genetically-engineered biological drugs, such as an autoinjector (pen injector device), can positively affect the organizational aspects of treating patients with severe eosinophilic asthma (SA) who need biological therapy.The aim. To determine the place of a new delivery device for benralizumab (autoinjector, pen injector device) in the clinical practice of treating eosinophilic SA.Results. The expert council considered the results of the latest clinical studies and real practice data on the use of genetically-engineered biological drugs in the form

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Cho, Kyungjoo, Simon Weonsang Ro, Sang Hyun Seo, et al. "Genetically Engineered Mouse Models for Liver Cancer." Cancers 12, no. 1 (2019): 14. http://dx.doi.org/10.3390/cancers12010014.

Повний текст джерела

Анотація:

Liver cancer is the fourth leading cause of cancer-related death globally, accounting for approximately 800,000 deaths annually. Hepatocellular carcinoma (HCC) is the most common type of liver cancer, comprising approximately 80% of cases. Murine models of HCC, such as chemically-induced models, xenograft models, and genetically engineered mouse (GEM) models, are valuable tools to reproduce human HCC biopathology and biochemistry. These models can be used to identify potential biomarkers, evaluate potential novel therapeutic drugs in pre-clinical trials, and develop molecular target therapies.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Samigullina, R. R., V. I. Mazurov, and E. A. Trofimov. "Characteristics of complex therapy of immuno-inflammatory rheumatic diseases in COVID-19 pandemic conditions." Russian Medical Inquiry 5, no. 5 (2021): 260–67. http://dx.doi.org/10.32364/2587-6821-2021-5-5-260-267.

Повний текст джерела

Анотація:

The rapid spread of a new coronavirus infection (COVID-19) requires innovative solutions, including tactics optimization in using genetically engineered and targeted drugs in patients with immuno-inflammatory rheumatic diseases (RD). The authors studied the characteristics of the complex therapy of immuno-inflammatory RD in the COVID-19 pandemic conditions, analyzed the COVID-19 course in patients with RD who received combined therapy with genetically engineered and basic synthetic anti-rheumatic drugs and were under follow-up from March 2020 to March 2021. The researchers found that synthetic

Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Genetically engineered drugs"

1

Mustafa, Suhad As'ad. "The development of genetically engineered bacterial enzymes as sensor biological recognition elements for the detection of drugs and explosives." Thesis, Bangor University, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.540409.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Creedon, Helen. "Use of genetically engineered mouse models in preclinical drug development." Thesis, University of Edinburgh, 2015. http://hdl.handle.net/1842/15911.

Повний текст джерела

Анотація:

The paucity of well validated preclinical models is frequently cited as a contributing factor to the high attrition rates seen in clinical oncological trials. There remains a critical need to develop models which are accurately able to recapitulate the features of human disease. The aims of this study were to use genetically engineered mouse models (GEMMs) to explore the efficacy of novel treatment strategies in HER2 positive breast cancer and to further develop the model to facilitate the study of mechanisms underpinning drug resistance. Using the BLG--HER2KI-PTEN+/- model, we demonstrated th

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Gning, Fatima. "Construction d’une usine pharmaceutique : impératifs réglementaires, sécuritaires et de rentabilité." Electronic Thesis or Diss., Université Paris-Panthéon-Assas, 2022. http://www.theses.fr/2022ASSA0078.

Повний текст джерела

Анотація:

L’industrie pharmaceutique est continuellement confrontée à d’importantes mutations qui redéfinissent sans cesse l’équilibre entre la protection de la santé publique et les stratégies de développement économique des sociétés pharmaceutiques. Le marché du médicament est le terrain de forts enjeux économiques pour la France et l’accroissement de ses parts de marché mondial reste une préoccupation majeure. L’atteinte de cet objectif semble se faire autour d’un premier axe ayant trait au développement du génie génétique. Le second axe concerne la construction de nouvelles usines de production à l’

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Jung, Lin Wan, and 林婉蓉. "Safety and Quality Regulation of Biomedicine in Taiwan and China: Focus on Genetically Engineered Drug." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/24410564380688915598.

Повний текст джерела

Анотація:

碩士<br>國立清華大學<br>科技法律研究所<br>103<br>As the problems of safety and drug tolerance of chemicals get ever more serious, the market of biomedicine grows rapidly to make up for the deficiencies of chemicals in remedial areas. Regulations in Taiwan and China and applications thereof which shall be followed through different stages when promoting genetic engineered medicine into market are discussed in this thesis. Since genetic engineered medicine is categorized as one sort of biomedicine, it should be in accordance with the rules set for biomedicine first and be further considered if regulations targ

Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Genetically engineered drugs"

1

Copsey, David N., and Sabine Y. J. Delnatte. Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

N, Copsey David, and Delnatte Sabine Y. J, eds. Genetically engineered human therapeutic drugs. Stockton Press, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Dictionary of Genetically Engineered Human Therapeutic Drugs. Pan Macmillan, 1988.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

GOVERNMENT, US. 21st Century Complete Guide to Biotechnology: Federal Research and Regulation, Bioengineered and Genetically Modified (GM) Crops, Seeds, Foods, and Drugs, Genetically Engineered Organisms, Agricultural Biotechnology (DVD-ROM). Progressive Management, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

US GOVERNMENT. 2005 Biotechnology Encyclopedia: Federal Research and Regulation, Bioengineered and Genetically Modified (GM) Crops, Seeds, Foods, and Drugs, Genetically Engineered (GE) Organisms, Agricultural Biotechnology, FDA, USDA, EPA, NIH, DOE (DVD-ROM). Progressive Management, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

US GOVERNMENT. 21st Century Essential Guide to Genetic Engineering and Biotechnology: Federal Research and Regulation, Bioengineered and Genetically Modified (GM) Crops, Seeds, Foods, and Drugs, Genetically Engineered (GE) Organisms, Agricultural Biotechnology, FDA, USDA, EPA, NIH, DOE (DVD-ROM). Progressive Management, 2005.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Bates, Gillian P., and Christian Landles. Preclinical Experimental Therapeutics. Oxford University Press, 2014. http://dx.doi.org/10.1093/med/9780199929146.003.0016.

Повний текст джерела

Анотація:

This chapter begins by reviewing the mammalian models of Huntington’s disease (HD) that have been developed using mice, rats, and a number of large animals, including sheep, pigs, and nonhuman primates. Analysis of these models, together with genetically engineered mice created through specific manipulations of the mouse genome, has provided considerable insights into the molecular pathogenesis of HD. The number of potential therapeutic targets that have been proposed for HD is considerable, and their preclinical evaluation in HD mouse models is being used to select targets that should be purs

Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Genetically engineered drugs"

1

Hentschel, Christopher. "Overview: Recombinant DNA Proteins and Drug Discovery." In Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2_1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Balkwill, Frances R. "Cytokines in Cancer Therapy." In Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2_2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Duff, Gordon W., Julian A. Symons, and Francesco S. Di Giovine. "Recombinant DNA Proteins and Prospects for Treatment of Inflammatory Diseases." In Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2_3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Tuddenham, Edward. "Cardiovascular and Blood-Related Proteins." In Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Gordon, Sarah L. "Overview of Commercial Prospects for Biotechnology Products in Health Care." In Genetically Engineered Human Therapeutic Drugs. Macmillan Education UK, 1988. http://dx.doi.org/10.1007/978-1-349-09800-2_5.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Gillies, Stephen D. "Designing immunocytokines: genetically engineered fusion proteins for targeted immune therapy." In Recombinant Protein Drugs. Birkhäuser Basel, 2001. http://dx.doi.org/10.1007/978-3-0348-8346-7_6.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Sacca, Rosalba, Sandra J. Engle, Wenning Qin, Jeffrey L. Stock, and John D. McNeish. "Genetically Engineered Mouse Models in Drug Discovery Research." In Methods in Molecular Biology. Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-058-8_3.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Carbajal, Eletha, and Eric C. Holland. "Mouse Models in Preclinical Drug Development: Applications to CNS Models." In Genetically Engineered Mice for Cancer Research. Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-69805-2_26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Loeber, Gerhard, and Renate Schnitzer. "The use of Genetically Engineered Cells in Drug Discovery." In Genetic Engineering. Springer US, 1998. http://dx.doi.org/10.1007/978-1-4899-1739-3_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Floyd, Warren, Hsuan-Cheng Kuo, Jonathon E. Himes, Rutulkumar Patel, and David G. Kirsch. "Genetically Engineered Mouse Models for Studying Radiation Biology and Radiosensitizers." In Cancer Drug Discovery and Development. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-49701-9_8.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Genetically engineered drugs"

1

Aksenova, Valentina, Nadezda Klevno, Elena Dementjeva, and Alexey Kazakov. "TB infection in children receiving genetically engineered biologic drugs." In ERS International Congress 2019 abstracts. European Respiratory Society, 2019. http://dx.doi.org/10.1183/13993003.congress-2019.pa3626.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Toner, Mehmet. "Moving Living Cells and Fluids on Microchips for Diagnostics." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192786.

Повний текст джерела

Анотація:

Biomedical applications of microfabricated devices is no longer limited to non-living systems as genes-on-a-chip or lab-on-a-chip, recent advances in the understanding of cellular behavior in microenvironments have started to pave the way toward living micro-devices. These emerging devices are expected to become key technologies in the 21st century of medicine with a broad range of applications varying from diagnostic, tissue engineered products, cell-based drug screening tools, and basic molecular biology tools. They will also include multiple cell types and/or genetically engineered cells to

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Silva, Maísa de Carvalho, Lariza Laura De Oliveira, and Renato Tinós. "Optimization of Expanded Genetic Codes via Genetic Algorithms." In XV Encontro Nacional de Inteligência Artificial e Computacional. Sociedade Brasileira de Computação - SBC, 2018. http://dx.doi.org/10.5753/eniac.2018.4440.

Повний текст джерела

Анотація:

In the last decades, researchers have proposed the use of genetically modified organisms that utilize unnatural amino acids, i.e., amino acids other than the 20 amino acids encoded in the standard genetic code. Unnatural amino acids have been incorporated into genetically engineered organisms for the development of new drugs, fuels and chemicals. When new amino acids are incorporated, it is necessary to modify the standard genetic code. Expanded genetic codes have been created without considering the robustness of the code. The objective of this work is the use of genetic algorithms (GAs) for

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Sharpless, Norman E. "Abstract CN03-01: Drug testing in genetically engineered murine models." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-cn03-01.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Qiu, Weiguo, Joseph Cappello, and Xiaoyi Wu. "Fabrication of Genetically Engineered Silk-Elastin-Like Protein Polymer Fibers." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-190980.

Повний текст джерела

Анотація:

Micro- and submicro-diameter protein fibers are fundamental building blocks of extra- and intra-cellular matrices, providing structural support, stability and protection to cells, tissues and organism [1]. Fabricating performance fibers of both naturally derived and genetically engineered proteins has been extensively pursued for a variety of biomedical applications, including tissue engineering and drug delivery [2]. Silk-elastin-like proteins (SELPs), consisting of tandemly repeated polypeptide sequences derived from silk and elastin, have been biosynthesized using recombinant DNA technique

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Teng, Weibing, Joseph Cappello, and Xiaoyi Wu. "Viscoelastic Properties of Genetically Engineered Silk-Elastin-Like Protein Polymers." In ASME 2008 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2008. http://dx.doi.org/10.1115/sbc2008-192252.

Повний текст джерела

Анотація:

Genetic engineering of protein-based materials provides material scientists with high levels of control in material microstructures, properties, and functions [1]. For example, multi-block protein copolymers in which individual block may possess distinct mechanical or biological properties have been biosynthesized [2, 3]. Polypeptide sequences derived from well-studied structural proteins (e.g., collagen, silk, elastin) are often used as motifs in the design and synthesis of new protein-based material, in which new functional groups may be incorporated. In this fashion, we have produced a seri

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Lowe, Scott W. "Abstract PL01-03: Drug resistance and tumor maintenance in genetically engineered mice." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-pl01-03.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Seidel, Diana, Anastasia Shibina, C. Patrick Reynolds, Winfried S. Wels, Nicole Huebener, and Holger N. Lode. "Abstract 2808: GD2-specific genetically engineered NK cell therapy is effective in a drug-resistant neuroblastoma xenograft mouse model." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-2808.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Lee, Edmund Chun Yu, Michael Fitzgerald, Bret Bannerman, et al. "Abstract 397: The antitumor activity of the investigational drug MLN9708 in genetically engineered mouse models of plasma cell malignancy." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-397.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Cuppoletti, John. "Composite Synthetic Membranes Containing Native and Engineered Transport Proteins." In ASME 2008 Conference on Smart Materials, Adaptive Structures and Intelligent Systems. ASMEDC, 2008. http://dx.doi.org/10.1115/smasis2008-449.

Повний текст джерела

Анотація:

Our membrane transport protein laboratory has worked with material scientists, computational chemists and electrical and mechanical engineers to design bioactuators and sensing devices. The group has demonstrated that it is possible to produce materials composed native and engineered biological transport proteins in a variety of synthetic porous and solid materials. Biological transport proteins found in nature include pumps, which use energy to produce gradients of solutes, ion channels, which dissipate ion gradients, and a variety of carriers which can either transport substances down gradie

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!